Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

40.79

-1.56 (-3.68%)

At close: Feb 27, 2026, 4:00 PM EST

41.11

+0.32 (0.78%)

After-hours: Feb 27, 2026, 7:22 PM EST

Vera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,911	3,595	2,678	683	535	569
Market Cap Growth	33.04%	34.24%	291.87%	27.69%	-5.87%	-
Enterprise Value	2,273	3,175	2,380	553	433	482
Last Close Price	40.79	50.64	42.29	15.38	19.35	26.72
PB Ratio	4.43	5.95	4.64	6.72	6.96	8.17
P/TBV Ratio	4.81	5.95	4.64	6.72	6.96	8.17
Debt / Equity Ratio	0.13	0.13	0.10	0.53	0.41	0.07
Net Debt / Equity Ratio	-1.05	-1.05	-1.02	-1.05	-1.08	-1.07
Net Debt / EBITDA Ratio	2.02	2.02	3.51	1.05	0.92	2.18
Net Debt / FCF Ratio	2.64	2.64	4.32	1.16	1.23	3.15
Quick Ratio	13.43	13.43	25.41	7.23	4.48	10.36
Current Ratio	13.64	13.64	25.67	7.71	4.91	10.73
Return on Equity (ROE)	-50.71%	-50.71%	-44.83%	-107.50%	-121.58%	-54.43%
Return on Assets (ROA)	-28.36%	-28.36%	-25.14%	-41.54%	-52.81%	-31.09%
Return on Capital Employed (ROCE)	-46.30%	-46.30%	-26.50%	-66.60%	-85.90%	-45.20%
Earnings Yield	-10.29%	-8.33%	-5.68%	-14.05%	-16.64%	-5.74%
FCF Yield	-	-6.73%	-5.07%	-13.50%	-12.64%	-4.17%
Buyback Yield / Dilution	-16.10%	-16.10%	-29.55%	-60.73%	-97.76%	-4099.14%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q